Updated Jul 16, 2026
Heidbreder Christian has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.47M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | INDV | Indivior Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 18.6K | $41.14 | $765K |
| 2026-06-12 | INDV | Indivior Pharmaceuticals, Inc. | S — Open-market sale | 18.6K | $38.06 | $707K |
| 2026-03-05 | INDV | Indivior Pharmaceuticals, Inc. | F — Tax withholding / forfeiture | 45.8K | $31.98 | $1.46M |
| 2026-03-05 | INDV | Indivior Pharmaceuticals, Inc. | M — Option exercise | 101.5K | — | |
| 2026-02-12 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 33.6K | $0.00 |
Heidbreder Christian is a corporate insider — currently tracked as Chief Scientific Officer of Indivior Pharmaceuticals, Inc. (INDV). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.47M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Heidbreder Christian profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.